Cargando…

Characterization of cutaneous adverse events to enfortumab vedotin: A retrospective case-control study

Detalles Bibliográficos
Autores principales: Shahin, Ahmad, Janeczek, Monica, Butterfield, Richard, Bhullar, Puneet, Boudreaux, Blake, Ho, Thai, Mangold, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706608/
https://www.ncbi.nlm.nih.gov/pubmed/36457993
http://dx.doi.org/10.1016/j.jdin.2022.10.004
_version_ 1784840541388668928
author Shahin, Ahmad
Janeczek, Monica
Butterfield, Richard
Bhullar, Puneet
Boudreaux, Blake
Ho, Thai
Mangold, Aaron
author_facet Shahin, Ahmad
Janeczek, Monica
Butterfield, Richard
Bhullar, Puneet
Boudreaux, Blake
Ho, Thai
Mangold, Aaron
author_sort Shahin, Ahmad
collection PubMed
description
format Online
Article
Text
id pubmed-9706608
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97066082022-11-30 Characterization of cutaneous adverse events to enfortumab vedotin: A retrospective case-control study Shahin, Ahmad Janeczek, Monica Butterfield, Richard Bhullar, Puneet Boudreaux, Blake Ho, Thai Mangold, Aaron JAAD Int Research Letter Elsevier 2022-10-30 /pmc/articles/PMC9706608/ /pubmed/36457993 http://dx.doi.org/10.1016/j.jdin.2022.10.004 Text en © 2022 Published by Elsevier Inc on behalf of the American Academy of Dermatology, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Shahin, Ahmad
Janeczek, Monica
Butterfield, Richard
Bhullar, Puneet
Boudreaux, Blake
Ho, Thai
Mangold, Aaron
Characterization of cutaneous adverse events to enfortumab vedotin: A retrospective case-control study
title Characterization of cutaneous adverse events to enfortumab vedotin: A retrospective case-control study
title_full Characterization of cutaneous adverse events to enfortumab vedotin: A retrospective case-control study
title_fullStr Characterization of cutaneous adverse events to enfortumab vedotin: A retrospective case-control study
title_full_unstemmed Characterization of cutaneous adverse events to enfortumab vedotin: A retrospective case-control study
title_short Characterization of cutaneous adverse events to enfortumab vedotin: A retrospective case-control study
title_sort characterization of cutaneous adverse events to enfortumab vedotin: a retrospective case-control study
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706608/
https://www.ncbi.nlm.nih.gov/pubmed/36457993
http://dx.doi.org/10.1016/j.jdin.2022.10.004
work_keys_str_mv AT shahinahmad characterizationofcutaneousadverseeventstoenfortumabvedotinaretrospectivecasecontrolstudy
AT janeczekmonica characterizationofcutaneousadverseeventstoenfortumabvedotinaretrospectivecasecontrolstudy
AT butterfieldrichard characterizationofcutaneousadverseeventstoenfortumabvedotinaretrospectivecasecontrolstudy
AT bhullarpuneet characterizationofcutaneousadverseeventstoenfortumabvedotinaretrospectivecasecontrolstudy
AT boudreauxblake characterizationofcutaneousadverseeventstoenfortumabvedotinaretrospectivecasecontrolstudy
AT hothai characterizationofcutaneousadverseeventstoenfortumabvedotinaretrospectivecasecontrolstudy
AT mangoldaaron characterizationofcutaneousadverseeventstoenfortumabvedotinaretrospectivecasecontrolstudy